Trials / Completed
CompletedNCT02160717
Risk of Diabetes in Young Turner Syndrome Patients
Beta-Cell Function in Young Turner Syndrome Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- Female
- Age
- 6 Years – 22 Years
- Healthy volunteers
- Accepted
Summary
Turner Syndrome is a common genetic disorder. Seventy percent of adults with Turner Syndrome have abnormalities in glucose metabolism which can lead to diabetes. The current screening guidelines for diabetes in Turner Syndrome are not specific and involve a fasting blood sugar once a year. The objective of this study is to determine if there are abnormalities in glucose metabolism and pancreatic function in young girls with Turner Syndrome. The study hypothesis is that pancreatic dysfunction (specifically of the beta cells that make insulin) is more prevalent in girls with Turner Syndrome compared to healthy controls.
Detailed description
The study will be conducted at Children's Hospital Medical Center, Cincinnati. The study will require 1 visit to the hospital where the subject will have an oral glucose tolerance test and a physical exam
Conditions
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2017-06-01
- Completion
- 2017-06-01
- First posted
- 2014-06-11
- Last updated
- 2017-08-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02160717. Inclusion in this directory is not an endorsement.